Treatment with SR140333 in combination with U0126 further reduced the cell viability compared with treatment with U0126 or SR140333 alone (Figure 3G), indicating that suppression of the ERK signaling increased the human CRC cells’ sensitivity to NK‐1R antagonist. The gene discussed is TACR1; the disease is colorectal carcinoma.